| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RecQ Helicases | 30 | 2023 | 35 | 8.480 |
Why?
|
| DNA Repair | 16 | 2021 | 198 | 2.440 |
Why?
|
| DNA Helicases | 17 | 2011 | 48 | 2.360 |
Why?
|
| DNA Damage | 15 | 2021 | 356 | 1.950 |
Why?
|
| Flap Endonucleases | 7 | 2015 | 8 | 1.660 |
Why?
|
| DNA | 19 | 2025 | 592 | 1.610 |
Why?
|
| DNA Replication | 11 | 2019 | 148 | 1.570 |
Why?
|
| Genomic Instability | 6 | 2022 | 37 | 1.460 |
Why?
|
| Protein Binding | 18 | 2025 | 1082 | 1.430 |
Why?
|
| Myocytes, Cardiac | 3 | 2023 | 183 | 1.430 |
Why?
|
| Superoxide Dismutase | 3 | 2023 | 158 | 1.410 |
Why?
|
| Oxidative Stress | 5 | 2023 | 1003 | 1.240 |
Why?
|
| DNA-Binding Proteins | 11 | 2025 | 561 | 1.230 |
Why?
|
| Breast Neoplasms | 7 | 2023 | 1723 | 1.190 |
Why?
|
| Exodeoxyribonucleases | 8 | 2014 | 17 | 1.090 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2025 | 56 | 1.090 |
Why?
|
| Adenosine Triphosphatases | 10 | 2016 | 83 | 1.040 |
Why?
|
| Infant Mortality | 2 | 2024 | 65 | 1.000 |
Why?
|
| Molecular Dynamics Simulation | 5 | 2025 | 188 | 1.000 |
Why?
|
| Maternal Mortality | 3 | 2025 | 26 | 0.950 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2023 | 734 | 0.940 |
Why?
|
| Caseins | 1 | 2025 | 15 | 0.930 |
Why?
|
| Bilirubin | 1 | 2025 | 18 | 0.920 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2025 | 10 | 0.920 |
Why?
|
| Maternal Health Services | 2 | 2024 | 23 | 0.900 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2025 | 67 | 0.850 |
Why?
|
| Mutagens | 3 | 2021 | 74 | 0.840 |
Why?
|
| Humans | 58 | 2026 | 43102 | 0.830 |
Why?
|
| Rifampin | 1 | 2023 | 8 | 0.830 |
Why?
|
| Lactoglobulins | 1 | 2023 | 15 | 0.810 |
Why?
|
| Molecular Mimicry | 1 | 2023 | 16 | 0.790 |
Why?
|
| Metalloporphyrins | 1 | 2023 | 12 | 0.790 |
Why?
|
| Tinea | 1 | 2023 | 8 | 0.780 |
Why?
|
| Genomics | 1 | 2025 | 293 | 0.770 |
Why?
|
| Thermodynamics | 1 | 2023 | 229 | 0.760 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2023 | 51 | 0.750 |
Why?
|
| Rotenone | 1 | 2022 | 17 | 0.740 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 218 | 0.740 |
Why?
|
| Hela Cells | 11 | 2015 | 376 | 0.710 |
Why?
|
| Antifungal Agents | 1 | 2023 | 169 | 0.680 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2020 | 30 | 0.650 |
Why?
|
| Neoplasms | 4 | 2021 | 1377 | 0.650 |
Why?
|
| Mitochondria | 2 | 2023 | 523 | 0.650 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2019 | 40 | 0.650 |
Why?
|
| Paraproteinemias | 1 | 2019 | 4 | 0.630 |
Why?
|
| Estrogens | 1 | 2021 | 203 | 0.610 |
Why?
|
| Deoxycytidine | 1 | 2019 | 38 | 0.600 |
Why?
|
| Antineoplastic Agents | 5 | 2019 | 1019 | 0.590 |
Why?
|
| Cell Line, Tumor | 9 | 2025 | 2676 | 0.570 |
Why?
|
| India | 5 | 2025 | 108 | 0.570 |
Why?
|
| Genome | 2 | 2019 | 149 | 0.560 |
Why?
|
| Chromatin | 3 | 2015 | 186 | 0.550 |
Why?
|
| Hemoglobinopathies | 1 | 2017 | 5 | 0.530 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2017 | 5 | 0.530 |
Why?
|
| Cytodiagnosis | 1 | 2016 | 10 | 0.510 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 13 | 0.510 |
Why?
|
| Hodgkin Disease | 1 | 2016 | 13 | 0.510 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 968 | 0.500 |
Why?
|
| Cell Movement | 5 | 2023 | 655 | 0.480 |
Why?
|
| Point Mutation | 1 | 2016 | 98 | 0.480 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2016 | 186 | 0.470 |
Why?
|
| Telomere | 3 | 2015 | 59 | 0.470 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2025 | 184 | 0.460 |
Why?
|
| Female | 18 | 2026 | 24698 | 0.450 |
Why?
|
| Hydroquinones | 1 | 2014 | 10 | 0.440 |
Why?
|
| Nucleic Acid Conformation | 6 | 2025 | 154 | 0.440 |
Why?
|
| Carrier Proteins | 1 | 2016 | 321 | 0.420 |
Why?
|
| DNA Repair Enzymes | 4 | 2008 | 22 | 0.410 |
Why?
|
| Benzo(a)pyrene | 1 | 2014 | 128 | 0.400 |
Why?
|
| Antigens, Nuclear | 1 | 2013 | 5 | 0.400 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 704 | 0.390 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 863 | 0.380 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 79 | 0.360 |
Why?
|
| Enzyme Inhibitors | 4 | 2013 | 458 | 0.350 |
Why?
|
| Filariasis | 3 | 2001 | 3 | 0.350 |
Why?
|
| Sister Chromatid Exchange | 2 | 2007 | 6 | 0.340 |
Why?
|
| Wuchereria bancrofti | 3 | 2001 | 3 | 0.340 |
Why?
|
| Estrogen Receptor alpha | 2 | 2022 | 121 | 0.330 |
Why?
|
| Gene Expression Regulation | 3 | 2022 | 1070 | 0.330 |
Why?
|
| Epigenesis, Genetic | 2 | 2026 | 291 | 0.310 |
Why?
|
| Animals | 16 | 2023 | 16992 | 0.310 |
Why?
|
| Recombinant Proteins | 5 | 2005 | 518 | 0.300 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 5 | 2011 | 6 | 0.300 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 5 | 2011 | 17 | 0.300 |
Why?
|
| Infant, Newborn | 4 | 2025 | 972 | 0.300 |
Why?
|
| Binding Sites | 4 | 2023 | 671 | 0.300 |
Why?
|
| Setaria Nematode | 2 | 1999 | 2 | 0.290 |
Why?
|
| Circular Dichroism | 2 | 2025 | 64 | 0.290 |
Why?
|
| Endonucleases | 2 | 2019 | 18 | 0.290 |
Why?
|
| Acetylcholinesterase | 2 | 1999 | 56 | 0.280 |
Why?
|
| Reactive Oxygen Species | 2 | 2022 | 532 | 0.280 |
Why?
|
| Emergency Medical Services | 2 | 2025 | 79 | 0.280 |
Why?
|
| Protein Structure, Tertiary | 8 | 2013 | 423 | 0.270 |
Why?
|
| Infant | 2 | 2024 | 1175 | 0.260 |
Why?
|
| Electrophoretic Mobility Shift Assay | 4 | 2013 | 54 | 0.260 |
Why?
|
| Chromosomal Instability | 1 | 2006 | 20 | 0.260 |
Why?
|
| Cell Line | 6 | 2023 | 1410 | 0.240 |
Why?
|
| Cell Proliferation | 6 | 2023 | 1455 | 0.240 |
Why?
|
| Radiochemistry | 1 | 2006 | 6 | 0.240 |
Why?
|
| DNA, Superhelical | 1 | 2006 | 7 | 0.240 |
Why?
|
| Nepal | 2 | 2024 | 19 | 0.240 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2005 | 47 | 0.240 |
Why?
|
| Adenosine Triphosphate | 4 | 2016 | 206 | 0.240 |
Why?
|
| DNA, Single-Stranded | 5 | 2006 | 40 | 0.240 |
Why?
|
| Werner Syndrome | 2 | 2005 | 3 | 0.230 |
Why?
|
| Models, Molecular | 2 | 2014 | 876 | 0.230 |
Why?
|
| Pregnancy | 4 | 2025 | 1772 | 0.230 |
Why?
|
| Female Urogenital Diseases | 1 | 2025 | 3 | 0.230 |
Why?
|
| Micelles | 1 | 2025 | 36 | 0.230 |
Why?
|
| Replication Protein A | 4 | 2017 | 8 | 0.230 |
Why?
|
| Menopause | 1 | 2025 | 64 | 0.220 |
Why?
|
| Recombination, Genetic | 4 | 2006 | 95 | 0.220 |
Why?
|
| Adolescent | 4 | 2023 | 6081 | 0.220 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 74 | 0.210 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2025 | 110 | 0.210 |
Why?
|
| RNA Interference | 3 | 2014 | 247 | 0.210 |
Why?
|
| Narration | 1 | 2024 | 37 | 0.210 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2023 | 13 | 0.210 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 290 | 0.210 |
Why?
|
| Escherichia coli Proteins | 1 | 2025 | 133 | 0.200 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2023 | 83 | 0.200 |
Why?
|
| Lactate Dehydrogenases | 1 | 2023 | 1 | 0.200 |
Why?
|
| Tryptophan | 1 | 2023 | 66 | 0.200 |
Why?
|
| Cardiolipins | 1 | 2023 | 12 | 0.200 |
Why?
|
| Quality of Health Care | 1 | 2024 | 161 | 0.190 |
Why?
|
| Aldehydes | 1 | 2023 | 70 | 0.190 |
Why?
|
| Amino Acid Sequence | 4 | 2016 | 1180 | 0.190 |
Why?
|
| Substrate Specificity | 4 | 2008 | 219 | 0.190 |
Why?
|
| Proteomics | 1 | 2025 | 378 | 0.190 |
Why?
|
| Child, Preschool | 2 | 2017 | 1546 | 0.190 |
Why?
|
| Male | 7 | 2023 | 23409 | 0.180 |
Why?
|
| Capillary Permeability | 1 | 2022 | 36 | 0.180 |
Why?
|
| Sequence Alignment | 2 | 2016 | 272 | 0.180 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2023 | 91 | 0.180 |
Why?
|
| Mice, Knockout | 2 | 2020 | 1035 | 0.180 |
Why?
|
| Energy Metabolism | 1 | 2023 | 187 | 0.180 |
Why?
|
| Adult | 6 | 2025 | 13872 | 0.180 |
Why?
|
| Cell Survival | 2 | 2023 | 945 | 0.180 |
Why?
|
| Aging | 1 | 2007 | 783 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2021 | 6 | 0.170 |
Why?
|
| Conserved Sequence | 2 | 2016 | 122 | 0.170 |
Why?
|
| Middle Aged | 5 | 2025 | 12222 | 0.170 |
Why?
|
| Catalytic Domain | 4 | 2014 | 118 | 0.170 |
Why?
|
| Fanconi Anemia | 3 | 2011 | 8 | 0.170 |
Why?
|
| Autophagy | 1 | 2022 | 140 | 0.170 |
Why?
|
| Base Sequence | 2 | 2016 | 983 | 0.170 |
Why?
|
| Child | 3 | 2017 | 3443 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 60 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 220 | 0.160 |
Why?
|
| Prevalence | 3 | 2025 | 1612 | 0.160 |
Why?
|
| Young Adult | 3 | 2023 | 5080 | 0.160 |
Why?
|
| Immunoprecipitation | 3 | 2012 | 127 | 0.160 |
Why?
|
| Keratin-19 | 1 | 2019 | 2 | 0.160 |
Why?
|
| Electrophoresis | 1 | 2019 | 24 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 26 | 0.160 |
Why?
|
| Kinetics | 4 | 2007 | 695 | 0.150 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 65 | 0.150 |
Why?
|
| Neurons | 1 | 2007 | 1263 | 0.150 |
Why?
|
| Rats | 2 | 2023 | 3735 | 0.150 |
Why?
|
| Oligonucleotides | 2 | 2013 | 49 | 0.150 |
Why?
|
| Antigens, Helminth | 1 | 1999 | 34 | 0.150 |
Why?
|
| Mice | 4 | 2023 | 6644 | 0.150 |
Why?
|
| Escherichia coli | 2 | 2016 | 460 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 590 | 0.140 |
Why?
|
| Cell Nucleus | 3 | 2012 | 383 | 0.140 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 706 | 0.140 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 259 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 159 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2023 | 1621 | 0.140 |
Why?
|
| Cell Cycle | 4 | 2019 | 346 | 0.140 |
Why?
|
| Protein Conformation | 3 | 2013 | 416 | 0.140 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3156 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2005 | 1124 | 0.140 |
Why?
|
| Transcription Factors | 3 | 2017 | 735 | 0.140 |
Why?
|
| Catalysis | 4 | 2006 | 187 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2005 | 458 | 0.130 |
Why?
|
| Apoptosis | 2 | 2023 | 1568 | 0.130 |
Why?
|
| Electrophoresis, Capillary | 1 | 2017 | 20 | 0.130 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 457 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 611 | 0.130 |
Why?
|
| Prognosis | 2 | 2016 | 861 | 0.130 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 21 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2017 | 103 | 0.130 |
Why?
|
| Lymph Nodes | 1 | 2016 | 74 | 0.120 |
Why?
|
| Incidence | 1 | 2019 | 1078 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 238 | 0.120 |
Why?
|
| Enzyme Activation | 3 | 2013 | 462 | 0.120 |
Why?
|
| Risk Factors | 2 | 2023 | 3994 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 2853 | 0.120 |
Why?
|
| Biological Products | 2 | 2013 | 91 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 465 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2014 | 20 | 0.110 |
Why?
|
| Benzoquinones | 1 | 2014 | 47 | 0.110 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2013 | 35 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 56 | 0.100 |
Why?
|
| Precipitin Tests | 2 | 2003 | 52 | 0.100 |
Why?
|
| Endodeoxyribonucleases | 2 | 2003 | 28 | 0.100 |
Why?
|
| Aged | 3 | 2025 | 8214 | 0.100 |
Why?
|
| Abortion, Legal | 1 | 2013 | 6 | 0.100 |
Why?
|
| Aphidicolin | 1 | 2013 | 3 | 0.100 |
Why?
|
| Lamin Type B | 1 | 2013 | 2 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2004 | 110 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2014 | 986 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2012 | 883 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 189 | 0.100 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2013 | 36 | 0.100 |
Why?
|
| Antitubercular Agents | 1 | 2013 | 35 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2017 | 2544 | 0.100 |
Why?
|
| Immunoblotting | 3 | 2013 | 181 | 0.100 |
Why?
|
| Lysophospholipids | 2 | 2023 | 20 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2004 | 199 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 150 | 0.090 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2012 | 12 | 0.090 |
Why?
|
| Oxidants | 1 | 2012 | 42 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2005 | 197 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2013 | 109 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 512 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 190 | 0.090 |
Why?
|
| Bloom Syndrome | 1 | 2011 | 1 | 0.090 |
Why?
|
| Ligands | 4 | 2014 | 388 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2011 | 240 | 0.080 |
Why?
|
| Time Factors | 2 | 2005 | 1857 | 0.080 |
Why?
|
| DNA, Cruciform | 2 | 2006 | 3 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2013 | 561 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 436 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2006 | 281 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2016 | 1271 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 1542 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 518 | 0.070 |
Why?
|
| Ethylmaleimide | 1 | 2007 | 8 | 0.070 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 2007 | 5 | 0.070 |
Why?
|
| Androstadienes | 1 | 2007 | 19 | 0.070 |
Why?
|
| Demecolcine | 1 | 2006 | 1 | 0.060 |
Why?
|
| Radiation, Ionizing | 1 | 2006 | 13 | 0.060 |
Why?
|
| Electroporation | 1 | 2006 | 21 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 114 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 58 | 0.060 |
Why?
|
| Cell Separation | 1 | 2007 | 94 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 1596 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 55 | 0.060 |
Why?
|
| Collodion | 1 | 2006 | 2 | 0.060 |
Why?
|
| Micropore Filters | 1 | 2006 | 2 | 0.060 |
Why?
|
| Plasmids | 1 | 2007 | 244 | 0.060 |
Why?
|
| DNA, Neoplasm | 1 | 2006 | 92 | 0.060 |
Why?
|
| HCT116 Cells | 2 | 2017 | 40 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 1001 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2006 | 97 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2025 | 34 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 182 | 0.060 |
Why?
|
| Acetylation | 1 | 2005 | 107 | 0.060 |
Why?
|
| Consensus | 1 | 2025 | 48 | 0.060 |
Why?
|
| Alleles | 1 | 2006 | 352 | 0.060 |
Why?
|
| Vaginal Diseases | 1 | 2025 | 9 | 0.060 |
Why?
|
| G-Quadruplexes | 1 | 2005 | 7 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 307 | 0.060 |
Why?
|
| Syndrome | 1 | 2025 | 73 | 0.060 |
Why?
|
| Ions | 1 | 2005 | 71 | 0.060 |
Why?
|
| Indoles | 1 | 2006 | 187 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 306 | 0.060 |
Why?
|
| Magnesium | 1 | 2005 | 94 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2004 | 56 | 0.050 |
Why?
|
| Postmenopause | 1 | 2025 | 141 | 0.050 |
Why?
|
| Hydroxyurea | 1 | 2004 | 34 | 0.050 |
Why?
|
| Amylose | 1 | 2003 | 5 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 78 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2003 | 183 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 39 | 0.050 |
Why?
|
| Registries | 1 | 2025 | 437 | 0.050 |
Why?
|
| Reperfusion | 1 | 2022 | 14 | 0.050 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2022 | 18 | 0.050 |
Why?
|
| Protein Interaction Mapping | 2 | 2013 | 65 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1869 | 0.040 |
Why?
|
| Brugia pahangi | 1 | 2001 | 1 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 333 | 0.040 |
Why?
|
| Carcinogens | 1 | 2021 | 126 | 0.040 |
Why?
|
| Antibodies, Helminth | 1 | 2001 | 24 | 0.040 |
Why?
|
| Phenotype | 1 | 2023 | 780 | 0.040 |
Why?
|
| Mutation | 3 | 2013 | 1177 | 0.040 |
Why?
|
| Cyclin D3 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 53 | 0.040 |
Why?
|
| Elephantiasis, Filarial | 1 | 1999 | 2 | 0.040 |
Why?
|
| Chromatography | 1 | 1999 | 17 | 0.040 |
Why?
|
| Rural Health | 1 | 1999 | 55 | 0.040 |
Why?
|
| Urban Health | 1 | 1999 | 101 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2022 | 329 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 139 | 0.040 |
Why?
|
| Buffaloes | 1 | 1998 | 3 | 0.030 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2017 | 2 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1998 | 87 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2016 | 84 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 118 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 161 | 0.030 |
Why?
|
| Age Factors | 1 | 1999 | 1154 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 368 | 0.030 |
Why?
|
| Sex Factors | 1 | 1999 | 1028 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 374 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 183 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2014 | 32 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2014 | 155 | 0.030 |
Why?
|
| Biocatalysis | 1 | 2013 | 30 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 25 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 41 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2013 | 74 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 712 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2013 | 144 | 0.030 |
Why?
|
| Multigene Family | 1 | 2013 | 105 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 127 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 237 | 0.020 |
Why?
|
| Caffeic Acids | 1 | 2013 | 5 | 0.020 |
Why?
|
| Disaccharides | 1 | 2013 | 12 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 83 | 0.020 |
Why?
|
| Morbidity | 1 | 2013 | 97 | 0.020 |
Why?
|
| Protein Stability | 1 | 2013 | 48 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2013 | 48 | 0.020 |
Why?
|
| Chromones | 1 | 2013 | 53 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 74 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 652 | 0.020 |
Why?
|
| Mortality | 1 | 2013 | 175 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 587 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1081 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 595 | 0.020 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2007 | 2 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2007 | 81 | 0.020 |
Why?
|
| Lysine | 1 | 2007 | 119 | 0.020 |
Why?
|
| Perylene | 1 | 2006 | 8 | 0.020 |
Why?
|
| Telomerase | 1 | 2006 | 42 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 201 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 173 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 213 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2005 | 32 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 257 | 0.010 |
Why?
|